This study is a prospective, randomized, open-label, two arms, clinical study aim to evaluate the efficacy and safety of treatment with Hyper-CL™ lens + Antibiotics compared with treatment with Antibiotics only, in subjects with Bacterial keratitis.
The design of the Hyper-CL™ lens increases contact time of the antibiotics on the cornea enabling increased bioavailability of the active drug.
- Study Type: Interventional
- Study Design
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Primary Purpose: Treatment
- Masking: None (Open Label)
- Study Primary Completion Date: February 2021
The Hyper-CL™ Therapeutic soft contact lenses for short-term wear (up to 7 days) are indicated for therapeutic use to promote corneal healing and relieve corneal pain by protecting the cornea during the treatment of acute or chronic pathologies, such as corneal edema, corneal erosions, entropion, bullous keratopathy, and corneal dystrophies as well as post-surgical conditions resulting from cataract extraction and corneal surgery.
- Device: Hyper-CL™ lens
- Use of the Hyper-CL™
Arms, Groups and Cohorts
- Experimental: Conventional Antibiotics+ Hyper-CL™ lens
- Conventional treatment with topical Antibiotics+ Hyper-CL™ lens
- No Intervention: Conventional Antibiotics
- Conventional treatment with topical Antibiotics
Clinical Trial Outcome Measures
- Improvement in Bacterial keratitis severity score.
- Time Frame: From date of randomization up to 14 days
- Will be measured by Bacterial keratitis severity score
Participating in This Clinical Trial
1. Subject is 18-86 years old
2. Subject with Bacterial keratitis in one eye only
1. Sign of inflammation in both eyes
3. Other active ocular infection
4. Any infiltration suggesting other than bacterial infection e.g. parasite, fungal
5. Any other condition which in the opinion of the investigator would place the patient at undue risk for participation.
6. Participation in another clinical study within the past 30 days
Gender Eligibility: All
Minimum Age: 18 Years
Maximum Age: 86 Years
Are Healthy Volunteers Accepted: No
- Lead Sponsor
- Eye-yon Medical
- Provider of Information About this Clinical Study
- Overall Contact(s)
- Lori Michaeli, MA, 972722052400, email@example.com
Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.